Remote Cardiac Monitoring and Wearables in 2026
Remote patient monitoring with wearables is transforming cardiology — from AF detection on smartwatches to AI-driven HF decompensation prediction. A 2026 review of evidence, devices, clinical applications, and implementation guidance.
HFpEF Treatment in 2026: New Therapeutic Pillars
HFpEF finally has its own therapeutic pillars. A 2026 review of SGLT2 inhibitors, finerenone (FINEARTS-HF), GLP-1 RAs (STEP-HFpEF, SUMMIT), and emerging combination strategies for heart failure with preserved ejection fraction.
AI-ECG Diagnosis: Hidden Cardiac Disease Detection in 2026
How AI-powered electrocardiogram analysis is detecting hidden cardiac diseases — from asymptomatic LV dysfunction to concealed atrial fibrillation — and reshaping clinical practice in 2026.
GLP-1 Receptor Agonists and Cardiovascular Outcomes in 2026
A comprehensive review of GLP-1 receptor agonists and their cardiovascular benefits beyond weight management, including MACE reduction, heart failure outcomes, and implications for clinical practice in 2026.